Compare OKYO Pharma Ltd. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.07%
0%
-26.07%
6 Months
-39.1%
0%
-39.1%
1 Year
68.14%
0%
68.14%
2 Years
31.94%
0%
31.94%
3 Years
-18.1%
0%
-18.1%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
OKYO Pharma Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-222.25%
EBIT to Interest (avg)
-2.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0
Tax Ratio
12.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.15%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-8.91
EV to EBIT
-4.04
EV to EBITDA
-4.04
EV to Capital Employed
-7.72
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 1 Schemes (0.04%)
Foreign Institutions
Held by 2 Foreign Institutions (2.87%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Mar'23
Mar'23
Mar'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-13.10
-6.20
-111.29%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-13.30
-5.40
-146.30%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Mar 2023 is 0.00% vs 0.00% in Mar 2022
Consolidated Net Profit
YoY Growth in year ended Mar 2023 is -146.30% vs -63.64% in Mar 2022
About OKYO Pharma Ltd. 
OKYO Pharma Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






